Bardet-Biedl Syndrome (BBS) belongs to a group of conditions called ciliopathies, where the root problem lies in tiny hair-like cellular structures called cilia that are essential to the normal working of several organs at once — including the retina, kidneys, and reproductive system. Vision loss is one of its most consistent features, but it exists alongside a wider set of systemic findings that Ghanaian families are often already managing with local physicians.
Because BBS affects the body as a whole, the retinal evaluation offered in India is deliberately narrow in scope: the team reviews existing records for the broader systemic picture, then concentrates the in-person visit on the eye-specific testing and care planning that requires equipment not typically available locally.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
“No — our evaluation and any retinal treatment address only the eye component. The systemic features of BBS, including weight management and kidney monitoring, need to continue under the relevant specialists managing those areas, ideally with information shared between the teams involved.”
”
In many cases, yes — central vision tends to be affected somewhat earlier in BBS compared with non-syndromic RP, which is one reason we generally recommend closer monitoring intervals for BBS patients.”
“Yes. Establishing a baseline ERG and OCT before symptoms become noticeable makes it far easier to detect and measure any change at future visits, and to plan low-vision support proactively rather than reactively.”
“Sharing the wider medical picture — not just prior eye reports — helps the team understand the full context of the syndrome, even though the in-person visit itself concentrates on retinal evaluation and care.”
